We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$637M
AUM Growth
+$19.4M
Cap. Flow
-$1.03M
Cap. Flow %
-0.16%
Top 10 Hldgs %
39.43%
Holding
77
New
1
Increased
27
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
NVRO
NEVRO CORP.
NVRO
+$3.63M
2
XRAY icon
Dentsply Sirona
XRAY
+$3.54M
3
ROST icon
Ross Stores
ROST
+$2.15M
4
SBUX icon
Starbucks
SBUX
+$1.59M
5
IP icon
International Paper
IP
+$1.22M

Top Sells

Rank Stock Value
1
GWW icon
W.W. Grainger
GWW
+$12.7M
2
CGNX icon
Cognex
CGNX
+$2.5M
3
WFC icon
Wells Fargo
WFC
+$1.6M
4
OXY icon
Occidental Petroleum
OXY
+$1.5M
5
IDXX icon
Idexx Laboratories
IDXX
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 43.36%
2 Technology 11.87%
3 Consumer Discretionary 11.15%
4 Industrials 10.86%
5 Miscellaneous 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGNX icon
1
Cognex
CGNX
$10.5B
$33.9M 5.32%
799,160
-56,320
-7% -$2.5M
TIF
2
DELISTED
Tiffany & Co.
TIF
$33.1M 5.2%
352,736
-2,260
-0.6% -$207K
JNJ icon
3
Johnson & Johnson
JNJ
$663B
$26.3M 4.12%
198,623
-2,283
-1% -$291K
ADI icon
4
Analog Devices
ADI
$176B
$25.5M 4.01%
328,315
+8,734
+3% +$694K
IDXX icon
5
Idexx Laboratories
IDXX
$42.2B
$24.9M 3.9%
154,000
-7,735
-5% -$1.26M
NEOG icon
6
Neogen
NEOG
$2.58B
$23.8M 3.74%
919,051
+5,094
+0.6% +$122K
RTN
7
DELISTED
Raytheon Company
RTN
$21.8M 3.43%
135,222
+2,030
+2% +$322K
HON icon
8
Honeywell
HON
$66.4B
$21.2M 3.32%
175,843
-858
-0.5% -$101K
DHR icon
9
Danaher
DHR
$146B
$20.5M 3.21%
273,467
+5,532
+2% +$414K
BF.B icon
10
Brown-Forman Class B
BF.B
$12.3B
$20.3M 3.18%
652,108
-22,953
-3% -$720K
BIIB icon
11
Biogen
BIIB
$32.6B
$20.3M 3.18%
74,704
-1,876
-2% -$496K
DXCM icon
12
DexCom
DXCM
$33.2B
$19.6M 3.07%
1,070,780
+24,100
+2% +$445K
MA icon
13
Mastercard
MA
$507B
$18.8M 2.95%
154,880
+1,210
+0.8% +$144K
HSIC icon
14
Henry Schein
HSIC
$10B
$18.2M 2.85%
253,072
+1,033
+0.4% +$72K
NVO
15
Novo Nordisk
NVO
$206B
$17.6M 2.76%
819,840
+7,450
+0.9% +$150K
INGN icon
16
Inogen
INGN
$144M
$15.9M 2.49%
166,140
+575
+0.3% +$49.1K
XRAY icon
17
Dentsply Sirona
XRAY
$2.27B
$15.8M 2.47%
243,211
+56,100
+30% +$3.54M
PODD icon
18
Insulet
PODD
$10.2B
$15.6M 2.45%
304,675
+3,120
+1% +$135K
AMGN icon
19
Amgen
AMGN
$236B
$14.1M 2.21%
81,734
-863
-1% -$140K
SBUX icon
20
Starbucks
SBUX
$119B
$13.9M 2.18%
237,850
+26,245
+12% +$1.59M
MTD icon
21
Mettler-Toledo International
MTD
$27B
$12.5M 1.95%
21,160
+15
+0.1% +$8.22K
ROST icon
22
Ross Stores
ROST
$73.7B
$11.7M 1.84%
203,280
+34,445
+20% +$2.15M
SLB icon
23
SLB Ltd
SLB
$85.3B
$11.7M 1.84%
177,886
-2,291
-1% -$164K
ABMD
24
DELISTED
Abiomed Inc
ABMD
$11.6M 1.82%
81,030
+325
+0.4% +$43.7K
ITW icon
25
Illinois Tool Works
ITW
$76.9B
$9.86M 1.55%
68,826
-150
-0.2% -$20.9K
1
2 3

Similar funds

IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
NTC
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return

Tirschwell & Loewy's Q2 2017 Portfolio in Review

As of Q2 2017, Tirschwell & Loewy held 77 positions worth $637M, up 3.1% from $618M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Tirschwell & Loewy's Q2 2017 filing shows 1 new, 27 increased, 33 reduced and 3 closed positions. Its largest new stake was NEVRO CORP.: 45,330 shares worth $3.37M. The largest sale was W.W. Grainger, an estimated $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 41% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Tirschwell & Loewy's largest Q2 2017 buy was NEVRO CORP.: 45,330 shares worth $3.37M.
  • Tirschwell & Loewy added most to Dentsply Sirona in Q2 2017, an estimated $3.54M increase.
  • Tirschwell & Loewy's biggest Q2 2017 reduction was Cognex, cutting an estimated $2.5M.
  • Tirschwell & Loewy fully exited W.W. Grainger in Q2 2017, selling an estimated $12.7M.
  • Tirschwell & Loewy's ten largest holdings make up 39% of its $637M portfolio in Q2 2017.
  • Tirschwell & Loewy opened 1 new position and closed 3 in Q2 2017.
  • Tirschwell & Loewy's portfolio value rose 3.1% quarter-over-quarter to $637M.

Based on Tirschwell & Loewy's 13F filing for Q2 2017, filed 2 Aug 2017.